Misra S - Search Results

1

Neurobiological aspects of Alzheimer's disease.

Chopra K, Misra S, Kuhad A. Chopra K, et al. Among authors: misra s. Expert Opin Ther Targets. 2011 May;15(5):535-55. doi: 10.1517/14728222.2011.557363. Epub 2011 Feb 11. Expert Opin Ther Targets. 2011. PMID: 21314231 Review.

2

Current perspectives on pharmacotherapy of Alzheimer's disease.

Chopra K, Misra S, Kuhad A. Chopra K, et al. Among authors: misra s. Expert Opin Pharmacother. 2011 Feb;12(3):335-50. doi: 10.1517/14656566.2011.520702. Epub 2011 Jan 11. Expert Opin Pharmacother. 2011. PMID: 21222549 Review.

3

Neurobiological effect of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in experimental paradigm of Alzheimer's disease.

Misra S, Kuhad A, Chopra K. Misra S, et al. Indian J Exp Biol. 2013 Dec;51(12):1086-93. Indian J Exp Biol. 2013. PMID: 24579374

4

Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats.

Misra S, Tiwari V, Kuhad A, Chopra K. Misra S, et al. Eur J Pharmacol. 2011 Jun 1;659(2-3):177-86. doi: 10.1016/j.ejphar.2011.03.026. Epub 2011 Apr 2. Eur J Pharmacol. 2011. PMID: 21463622

5

Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease.

Misra S, Chopra K, Saikia UN, Sinha VR, Sehgal R, Modi M, Medhi B. Misra S, et al. Regen Med. 2016 Oct;11(7):629-46. doi: 10.2217/rme-2016-0032. Epub 2016 Sep 1. Regen Med. 2016. PMID: 27582416

6

Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence.

Sachdeva AK, Misra S, Pal Kaur I, Chopra K. Sachdeva AK, et al. Among authors: misra s. Eur J Pharmacol. 2015 Jan 15;747:132-40. doi: 10.1016/j.ejphar.2014.11.014. Epub 2014 Nov 20. Eur J Pharmacol. 2015. PMID: 25449035

7

Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations.

Misra S, Chopra K, Sinha VR, Medhi B. Misra S, et al. Drug Deliv. 2016 May;23(4):1434-43. doi: 10.3109/10717544.2015.1089956. Epub 2015 Sep 25. Drug Deliv. 2016. PMID: 26405825

8

Drug development status for Alzheimer's disease: present scenario.

Misra S, Medhi B. Misra S, et al. Neurol Sci. 2013 Jun;34(6):831-9. doi: 10.1007/s10072-013-1316-x. Epub 2013 Feb 8. Neurol Sci. 2013. PMID: 23392897 Review.

9

Advances in drug development for Parkinson's disease: present status.

Harikrishna Reddy D, Misra S, Medhi B. Harikrishna Reddy D, et al. Among authors: misra s. Pharmacology. 2014;93(5-6):260-71. doi: 10.1159/000362419. Epub 2014 Aug 1. Pharmacology. 2014. PMID: 25096413 Free article. Review.

10

Microarray in parasitic infections.

Sehgal R, Misra S, Anand N, Sharma M. Sehgal R, et al. Among authors: misra s. Trop Parasitol. 2012 Jan;2(1):6-12. doi: 10.4103/2229-5070.97232. Trop Parasitol. 2012. PMID: 23508469 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,851 results

Search Page